Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A study in the September issue of the American Journal of Gastroenterology shows that HIV'hepatitis C and HIV'hepatitis B coinfected patients report a similar overall quality of life as patients infected only with HIV. All of the study subjects reported similar scores for mental and physical health, the researchers noted. Hepatitis C virus is found much more frequently in the semen of HIV-HCV coinfected men than in those only infected with hepatitis, researchers reported in the November 4 issue of the journal AIDS. An analysis of semen samples from HCV-infected men showed that 38% of the samples from coinfected men had detectable hepatitis virus, compared to 18% of the samples from men infected only with HCV. The researchers theorize that HCV transfers between the blood and the semen more easily in HIV-positive men. HCV may be compartmentalized in the genital tracts of HIV-HCV coinfected women, where it replicates independently of virus in the bloodstream, according to a study in the November 1 issue of The Journal of Infectious Diseases. The researchers say HCV was detected in cervicovaginal fluids from 31% of coinfected women, compared to none of the women infected only with HCV. Although the researchers are unsure why virus was frequently detected in the genital tracts of coinfected women, they theorize that HIV and HCV may be infecting the same cells, resulting in increased HCV replication, or that HIV-related immune system damage may allow both viruses to more easily replicate. HCV infection in the brain could be linked with the development of neurological ailments in HIV-HCV coinfected patients, researchers report in the October issue of the journal AIDS. HCV has been detected in autopsied brain tissue, particularly in certain macrophages and microglia, raising the possibility that hepatitis could be directly linked to cognitive changes in coinfected patients. Shorter treatment of HCV infection with Pegasys and ribavirin may be possible for so-called 'super responders,' patients who achieve dramatically lowered blood-based viral levels after four weeks of treatment, researchers reported at the American Association for the Study of Liver Diseases conference. Super responders are able to successfully treat HCV with only 24 weeks of therapy, compared to the standard 48 weeks required for those responding more slowly to the medications, according to the study. A study in the November issue of the journal Hepatology has shown that Interleukin-12, while a common component of combination hepatitis B treatment, does stop HBV replication when dosed on its own. IL-12 did, however, boost the antiviral effects of Epivir, resulting in a greater increase in virus-specific T-cell activity and interferon-gamma production. The Schering Plough experimental hepatitis C treatment SCH 503034 has significant antiviral activity in HCV patients for whom standard Pegasys and ribavirin therapy is failing, researchers reported at the American Association for the Study of Liver Diseases conference. HCV viral load reductions were detected in study subjects within 24 hours of the first dose, and patients who received 400-milligram doses three times daily experienced the most significant drops in viral levels. VX-950, an experimental hepatitis C protease inhibitor in development by Vertex Pharmaceuticals, was shown in a Phase IB clinical trial to be well-tolerated and also to have substantial antiviral effects. Additional studies are planned to better gauge the compound's ability to inhibit HCV replication. Roche is expanding its large-scale study comparing hepatitis C treatment response rates between Latinos and whites to better fight HCV among the Latino population, where hepatitis infections are more common. Some studies also have shown HCV to progress faster to cirrhosis and liver failure in Latinos than in whites or African-Americans. Roche is expanding the study of Pegasys and Copegus (ribavirin) treatment to 60 trial sites in Puerto Rico and other parts of the United States.
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
The freedom of disclosure: David Anzuelo's journey through HIV, art, and advocacy
August 02 2024 12:21 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Plus: Featured Video
Latest Stories
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM
The Trevor Project receives $5M grant to support LGBTQ+ youth mental health in rural Midwest (exclusive)
September 03 2024 9:30 AM
Introducing 'Health PLUS Wellness': The Latinx Issue!
August 30 2024 3:06 PM
La ciencia detrás de U=U ha estado liberando a las personas con VIH durante años
August 23 2024 2:48 PM
Tratamiento y prevención del VIH por inyección: Todo lo que necesita saber
August 23 2024 2:41 PM
Sr. Gay World quiere asegurarse de que estés bien
August 23 2024 2:30 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
With a new case in Sweden, what is the new mpox outbreak and should you be concerned?
August 15 2024 4:48 PM
From ‘The Real World’ to real life: How Danny Roberts thrives with HIV
July 31 2024 5:23 PM
The July/Aug 'Treatment Guide' issue of Plus is here!
June 26 2024 3:49 PM
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM